Related Experiment Video
Updated: Mar 15, 2026
10:46
A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
4.5K
[DNA aptamers selection for breast cancer]
G S Zamay1, I V Belayanina2, A S Zamay2
1Kirensky Institute of Physics, Krasnoyarsk, Russia; Voino-Yasenetski Krasnoyarsk State Medical University, Krasnoyarsk, Russia.
Biomeditsinskaia Khimiia
|August 27, 2016
Summary
Researchers developed a method to select DNA aptamers that specifically bind to breast tumor tissue. These aptamers show potential for breast cancer diagnostics and targeted drug delivery.
Area of Science:
- Biotechnology
- Molecular Biology
- Oncology
Background:
- Developing targeted therapies and diagnostic tools for breast cancer is crucial.
- DNA aptamers offer a promising alternative to antibodies for molecular recognition.
Purpose of the Study:
- To develop a method for selecting DNA aptamers that selectively bind to breast tumor tissue.
- To identify DNA aptamers for potential use in breast cancer diagnostics and therapeutics.
Main Methods:
- Selection of DNA aptamers using postoperative breast tumor tissue as the positive target.
- Utilized benign tumor tissue, adjacent healthy tissues, and other malignant tumor tissues as negative targets.
- Employed subtractive selection to obtain aptamers with high specificity for cancer cells.
Main Results:
- A pool of DNA aptamers demonstrating selective binding to breast cancer cells and tissues was obtained.
- The selected aptamers showed insignificant binding to benign breast tissues.
- This indicates high specificity of the developed aptamer pool for malignant breast tissue.
Conclusions:
- The developed DNA aptamers are highly specific for breast tumor tissue.
- These aptamers hold potential for identifying protein markers in breast cancer.
- Applications include breast cancer diagnostics and targeted delivery of anticancer drugs.
